M. Uszyński / Open Journal of Obstetrics and Gynecology 1 (2011) 178-183
182
cerning controlled heparin therapy in the first phase of
typical embolism (for ref. see: [31]).
REFERENCES
[1] Abenhaim, H.A., Azoulay, L., Kramer, M.S. and Leduc,
L. (2008) Incidence and risk factors of amniotic fluid
embolismus: A population-based study on 3 million bir-
ths in the United States. American Journal of Obstetrics
and Gynecology, 199, E1-E8.
doi:10.1016/j.ajog.2007.11.061
[2] Clark, S.L, Hankins, G.D.V., Dudley, D.A. and Dildy,
G.A. (1995) Amniotic fluid embolism: Analysis of the na-
tional registry. American Journal of Obstetrics and Gy-
necology, 172, 1158-1169.
doi:10.1016/0002-9378(95)91474-9
[3] Steiner, P.E. and Lushbaugh, C.C. (1941) Maternal pul-
monary embolism by amniotic fluid as a cause of obstet-
ric shock and unexpected deaths in obstetrics. Journal of
the American Medical Association, 11 7, 1245-1254.
[4] Meyer, J.R. (1992) Embolia pulmonary amnio caseosa.
Clinics in Chest Medicine, 13, 657-665.
[5] McDougall, R.J. and Duke, G.J. (1995) Amniotic fluid
embolism syndrome: Case report and review. Anaesthe-
sia and Intensive Care, 23, 735-740.
[6] Bastien, J.L., Graves, J.R. and Bailey, S. (1998) Atypical
presentation of amniotic fluid embolism. Anesthesia and
Analgesia, 87, 124-126.
doi:10.1097/00000539-199807000-00027
[7] Fletcher, S.J. and Parr, M.J.A. (2000) Amniotic fluid
embolism: A case report and review. Resuscitation, 43,
141-146. doi:10.1016/S0300-9572(99)00140-9
[8] Awad, I.T. and Shorten, G.D. (2001) Amniotic fluid em-
bolism and isolated coagulopathy: Atypical presentation
of amniotic fluid embolism. European Journal of Anas-
thesiology, 18, 410-413.
doi:10.1097/00003643-200106000-00011
[9] Weiner, A.E., Reid, D.E. and Roby, C.C. (1949) Hemo-
static activity of amniotic fluid. Science, 11 0, 190.
doi:10.1126/science.110.2851.190
[10] Clark, S.L. (1985) Arachidonic acid metabolites and the
pathophysiology of amniotic fluid embolism. Seminars in
Reproductive Endocrinology, 3, 253-257.
doi:10.1055/s-2007-1022623
[11] Azegami, M. and Mori, N. (1986) Amniotic fluid embo-
lism and leukotriens. American Journal of Obstetrics and
Gynecology, 155, 1119-1124.
[12] Clark, S.L. (1990) New concept of amniotic fluid embo-
lism: A review. Obstetrical and gynecological survey, 45,
360-368. doi:10.1097/00006254-199006000-00003
[13] el-Maradny, E., Kanayama, N., Halim, A., Maehara, K.
and Taro, T. (1995) Endothelin has a role in the early pa-
thogenesis of amniotic fluid embolism. Gynecologic and
Obstetric Investigation, 40, 14-18.
doi:10.1159/000292294
[14] Khong, T. (1998) Expression of endothelin-1 in amniotic
fluid embolism and possible pathophysiological mecha-
nism. British Journal of Obstetrics and Gynaecology,
105, 802-804. doi:10.1111/j.1471-0528.1998.tb10214.x
[15] Robillard, J., Gauvin, F., Molinaro, G., Leduc, L., Adam,
A. and Rivard, G.E. (2005) The syndrome of amniotic
fluid embolism: A potential contribution of bradykinin.
American Journal of Obstetrics and Gynecology, 193,
1508-1512. doi:10.1016/j.ajog.2005.03.022
[16] Mutoh, S., The, A., Sato, M., Aoki, N., Ohno, Y. and Itoh,
N. (1989) Studies on coagulation-fibrinolysis and Kal-
likrein-kinin systems and kininase activity and kininase
II quantity in amniotic fluid. Advances in Experimental
Medicine and Biology, 247, B559-B567.
[17] Zhou, J., Liu, S., Ma, M., Hou, J., Yu, H., Lu, Ch., Gil-
bert, G. and Jialan, S. (2009) Procoagulant activity and
phosphatidylserine of amniotic fluid cells. Thrombosis
and Haemostasis, 101, 845-851.
[18] Brace, R.A. (1999) Physiology of amniotic fluid volume
regulation. In: Amniotic fluid. Rao, K.A. and Ross, M.G.,
Eds., Prism Books Pvt Ltd., Bangalore, S110-S132.
[19] Tyden, O., Bergström, S. and Nilsson, B.A. (1980) Ori-
gin of amniotic fluid cells in mid-trimester pregnancies.
British Journal of Obstetrics and Gynaecology, 88, 278-
286.
[20] Lockwood, C.J., Bach, R., Guha, A., Zhou, X., Miller,
W.A. and Nemerson, Y. (1991) Amniotic fluid contains
tissue factor, a potent initiator of coagulation. American
Journal of Obstetrics and Gynecology, 165, 1335-1341.
[21] Uszyński, M. and Uszyński, W. (2011) Coagulation and
fibrinolysis in amniotic fluid: Physiology and observa-
tions on amniotic fluid embolism, preterm fetal mem-
brane rupture, and pre-eclampsia. American Journal of
Obstetrics and Gynecology, 37, 165-174.
[22] Uszyński, M. (1999) Fibrinolytic system in amniotic
fluid and foetal membranes. In: Amniotic fluid. Rao, A.
and Ross, M.G. (red.) Prism Books Pvt Ltd. Bangalore,
163-175.
[23] Slunsky, R. (1971) Klinik der Fruchtwasserembolie. Kar-
ger, Basel.
[24] Hoffman, M. and Monroe III, D.M. (2001) A cell-based
model of hemostasis. Thrombosis and Haemostasis, 85,
958-965.
[25] Schneider, ChL. (1957) Fibrination and defibrination. In:
Physiologie und pathologie der blutgerinnung in der ges-
tationsperiode. Schattauer-Verlag, Stuttgart, 15-17.
[26] Phillips, L.L. and Davidson, E.C. (1972) Procoagulant
properties of amniotic fluid. American Journal of Obstet-
rics and Gynecology, 113, 911-919.
[27] MacMillan, D. (1968) Experimental amniotic fluid infu-
sion. Journal of obstetrics and gynaecology of the British
Commonwealth, 75, 849-852.
doi:10.1111/j.1471-0528.1968.tb01604.x
[28] Uszyński, M., Żekanowska, E., Uszyński, W. and Kuc-
zyński, J. (2001) Tissue factor (TF) and tissue factor
pathway inhibitor (TFPI) in amniotic fluid and blood
plasma: Implications for the mechanism of amniotic fluid
embolism. European Journal of Obstetrics and Gyneco-
logy and Reproductive Biology, 95, 163-166.
doi:10.1016/S0301-2115(00)00448-6
[29] Esposito, R.A., Grossi, E.A., Coppa, G., Gianola, G.,
Ferri, D.P., Angelides, E.M. and Andriakos, P. (1990) Su-
ccesful treatment of shock caused by amniotic fluid em-
bolism with cardiopulmonary bypass and pulmonary ar-
tery thromboembolectomy. American Journal of Obstet-
rics and Gynecology, 163, 572-574.
[30] Stanten, R.D., Iverson, I.G., Daugharty, T.M., Lovett,
S.M., Terrt, C. and Blumenstock, E. (2003) Amniotic flu-
C
opyright © 2011 SciRes. OJOG